ePrints

Botulinum toxin for drooling in Parkinson's disease

Lookup NU author(s): Emeritus Professor Nick Miller

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Abstract

© 2016 The Cochrane Collaboration.This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: Primary objective: to assess the efficacy of botulinum toxin treatment to reduce or eliminate drooling in adults with Parkinson's disease. Secondary objective: to assess the adverse effects of botulinum toxin treatment for drooling in adults with Parkinson's disease.

Publication metadata

Author(s): Hill F, Miller N, Walsh RA, Mockler D, McDowell R, Walshe M

Publication type: Article

Publication status: Published

Journal: Cochrane Database of Systematic Reviews

Year: 2016

Volume: 2016

Issue: 10

Online publication date: 28/10/2016

Acceptance date: 02/04/2016

ISSN (print): 1469-493X

ISSN (electronic): 1361-6137

Publisher: John Wiley and Sons Ltd

URL: https://doi.org/10.1002/14651858.CD012408

DOI: 10.1002/14651858.CD012408

Altmetrics

Share